Cartesian Therapeutics, Inc. (RNAC) insider trading

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Timothy C Barabe

Director

$205.80K (1)

—

+$205.80K

56,966

0.1883%

$388.49K

+161.7%

Carsten Brunn

President and CEO

—

$162.08K (1)

−$162.08K

323,530

1.07%

$2.21M

+97.4%

Blaine Davis

Chief Financial Officer

—

$72.23K (1)

−$72.23K

121,220

0.4007%

$826.68K

+50.0%

Milos Miljkovic

Chief Medical Officer

—

$24.37K (1)

−$24.37K

58,820

0.1944%

$401.13K

+221.9%

Timothy A Springer

Director

—

9,302,798

30.75%

$63.44M

+8.8%

Murat Kalayoglu

10% owner

—

5,824,838

19.25%

$39.72M

+15.1%

Elizabeth Hoge

10% owner

—

5,313,261

17.56%

$36.23M

+16.6%

Emily English

Chief Operations Officer

—

94,226

0.3114%

$642.59K

+415.7%

Christopher M Jewell

Chief Scientific Officer

—

62,490

0.2065%

$426.16K

+140.9%

Metin Kurtoglu

Chief Technology Officer

—

62,258

0.2058%

$424.58K

+22.0%

Michael Singer

Director

—

49,578

0.1639%

$338.11K

−58.6%

Carrie Smith Cox

Director

—

15,629

0.0517%

$106.59K

+20.0%

Patrick J Zenner

Director

—

12,974

0.0429%

$88.48K

+66.9%

Nishan M DeSilva

Director

—

11,366

0.0376%

$77.51K

+84.3%

Kemal Malik

Director

—

11,133

0.0368%

$75.92K

+87.6%

June Ann Seymour

Chief Accounting Officer

—

6,500

0.0215%

$44.33K

—

Adrian Ion Bot

Director

—

5,800

0.0192%

$39.55K

—

Cartesian Therapeutics, Inc.

What the insiders did Net selling

By person